Posts for Ticker ‘LWSN’

Soros Fund Holdings

Yesterday Soros Fund Management Filed a 13-F outlining the fund’s long portfolio as of September 30th, 2009.  The total value of the holdings reported in the filing is $6,198,089.  Twenty holdings represented roughly 50% of the value.  Soros Fund Management is a hedge fund management company that invests primarily based on macroeconomic analysis.  It should be noted that the fund’s equity portfolio likely contains significant short positions, which are not reported in 13-F filings.  Some of the positions in the filing may be in place as hedges or part of a multi-part trade, rather than a directional bet.  With that in mind, a glance at this firm’s major holdings provides clues to its macroeconomic outlook.  

Total stakes in Petroleo Brasileo Brasileiro (NYSE: PBR) represent 9.23% of the value of the positions reported in the filing, with just over 13 million shares held.  This is down from by 2.3 million from the fund’s last filing. Read More »

Posted on: November 17, 2009 – 10:52 am in Uncategorized, , , , , , , , , , , , , , , , , , , , ,

Major Market Movers (10/1/2009) (UAUA)(ASTI)(RVSN)

According to Volume Spike Investor,  several stocks are making major move before the open.

UAL (UAUA) is tanking (details) Ascent Solar (ASTI) is off sharply on a new stock offering (details)

RADVision (RVSN) is down as customer Cisco (CSCO) buys Tandberg. (detail)  Lawson (LWSN) is up on earnings. (details).  And, Catalyst Pharm (CPRX) is higher on drug trial news  (details).

Douglas A. McIntyre

Posted on: October 1, 2009 – 8:32 am in Pre-Market Activity, , , , , ,

After Disappointing Report, Is Lawson Still Potential Merger Bait? (LWSN)

Lawson Software (NASDAQ: LWSN) may be in a strange spot now as the enterprise software and consultant firm issued earnings. 

The company posted earnings of $0.08 EPS on a non-GAAP basis on an 11.3% rise in revenues to $212.9 million, while First Call showed consensus as $0.08 EPS and $217.2 million.  Lawson issued guidance for next quarter at $0.08 to $0.11 EPS on revenues of $225 to $230 million.  This is still sequential growth, but this lurks under the estimates of $0.12 EPS and $230.9 million from First Call.  As far as charges, Lawson reported an additional permanent impairment charge of $8.1 million.  It also reported a temporary impairment charge of $2.1 million to reduce the value of its auction rate securities.

The company is still growing and it isn’t an expensive enterprise software and consulting company if you are willing to stick by some longer-term forecasts out to Mid-2009.  But the problem is that this new drop might make the required premium to secure a vote approval too high, assuming the company would even go along with a buyout if it came.

If a buyout offer ever comes for Lawson, it has to be a "friendly" merger.  The company has both a blank-check preferred share provision and a poison pill provision according to Capital IQ.

If you would like to join our open email distribution list,we usually discuss other merger candidates, merger-arb, specialfinancings, and other issues that create special situations.  We havealso reviewed this for our weekly "10 Stocks Under $10" newsletter.

Lawson has been public for now more than 5-years and for most of that time it has traded between $5.00 and $10.00 per share.  The company’s stock closed up 1% at $8.00 in regular trading today, yet shares are down roughly 8% at $7.30 in after-hours trading.  Its 52-week trading range is $6.94 to $11.39.

Jon C. Ogg
April 3, 2008

Jon Ogg produces the Special Situation Investing Newsletter; he does not own securities in the companies he covers.

Posted on: April 3, 2008 – 3:49 pm in Earnings, Earnings Warning, Mergers and Buy Outs, Software,

Pre-Market Stock News (June 13, 2007)

(AOB) American Oriental enters into a letter-of-intent to acquire an established plant based pharmaceutical company named Changchun Xinan Pharmaceutical Group for up to $30 million.
(CEN) Ceridian largest shareholder says the private equity buyout is underpriced.
(EBAY) eBay is still in court over this MercExchange LLC patent over its “Buy It Now” patent.
(F) Ford confirmed that it is reviewing sales of Jaguar and Rover; Goldman Sachs and others hired.
(GWR) Genesee & Wyoming reported a total carload decrease of 0.3%.
(GYI) Getty Images announced it has filed its 10-K for 2006.
(HS) Healthspring lowered guidance.
(LWSN) Lawson Software raised guidance to $0.05 to $0.07 EPS vs $0.04e.
(MAGS) Magal Security announced a new strategic partnership in Brazil for services providers.
(PAY) VeriFone Holdings announced it has been selected as the sole provider of electronic payment systems by the China Postal Savings Bank.
(POR) Portland General Electric announced the pricing of a 21 million share secondary at $26.00; seller is Enron Disputed Claims Reserve.
(SAPE) Sapient $0.07 EPS vs $0.01+e.
(SHLM) A. Schulman lowered guidance.
(SNY) Sanofi-Aventis diet drug all in one pill is being reviewed; already marketed as Acomplia in other countries.
(SSYS) Stratasys will replace LSS on S&P Small Cap 600 Index on June 14.
(TYC) Tyco will take a $500 Million pre-tax and $370 million after tax impairment charge for the sale of its Power Systems business.
(VLCM) Volcom will replace PXR on the S&P Small Cap 600 Index on June 15.

Jon C. Ogg
June 13, 2007

Jon Ogg can be reached at jonogg@247wallst.com; he does not own securities in the companies he covers.

Posted on: June 13, 2007 – 6:51 am in Pre-Market Activity, , , , , , , , , , , , , , , , ,